111 related articles for article (PubMed ID: 2573423)
1. Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells.
Griffig J; Koob R; Blakley RL
Cancer Res; 1989 Dec; 49(24 Pt 1):6923-8. PubMed ID: 2573423
[TBL] [Abstract][Full Text] [Related]
2. Biochemical pharmacology of 2-chlorodeoxyadenosine in malignant human hematopoietic cell lines and therapeutic effects of 2-bromodeoxyadenosine in drug combinations in mice.
Avery TL; Rehg JE; Lumm WC; Harwood FC; Santana VM; Blakley RL
Cancer Res; 1989 Sep; 49(18):4972-8. PubMed ID: 2569929
[TBL] [Abstract][Full Text] [Related]
3. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
Wilson JM; Mitchell BS; Daddona PE; Kelley WN
J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
[TBL] [Abstract][Full Text] [Related]
4. Effects of cytotoxicity of 2-chloro-2'-deoxyadenosine and 2-bromo-2'-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics.
Huang MC; Ashmun RA; Avery TL; Kuehl M; Blakley RL
Cancer Res; 1986 May; 46(5):2362-8. PubMed ID: 2421877
[TBL] [Abstract][Full Text] [Related]
5. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
Ross DD; Akman SA; Schrecker AW; Bachur NR
Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
[TBL] [Abstract][Full Text] [Related]
6. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine.
Kinahan JJ; Otten M; Grindey GB
Cancer Res; 1979 Sep; 39(9):3531-9. PubMed ID: 476679
[TBL] [Abstract][Full Text] [Related]
8. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.
Parker WB; Shaddix SC; Chang CH; White EL; Rose LM; Brockman RW; Shortnacy AT; Montgomery JA; Secrist JA; Bennett LL
Cancer Res; 1991 May; 51(9):2386-94. PubMed ID: 1707752
[TBL] [Abstract][Full Text] [Related]
9. Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.
Carrera CJ; Terai C; Lotz M; Curd JG; Piro LD; Beutler E; Carson DA
J Clin Invest; 1990 Nov; 86(5):1480-8. PubMed ID: 1700795
[TBL] [Abstract][Full Text] [Related]
10. Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine.
Xie KC; Plunkett W
Cancer Res; 1996 Jul; 56(13):3030-7. PubMed ID: 8674058
[TBL] [Abstract][Full Text] [Related]
11. Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase.
Parker WB; Bapat AR; Shen JX; Townsend AJ; Cheng YC
Mol Pharmacol; 1988 Oct; 34(4):485-91. PubMed ID: 3050447
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of herpes simplex virus replication by purine deoxyribonucleosides.
North TW
Cancer Res; 1984 Apr; 44(4):1415-9. PubMed ID: 6322976
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
Matsumoto SS; Yu J; Yu AL
J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
[TBL] [Abstract][Full Text] [Related]
14. On the mechanism of deoxyribonucleoside toxicity in human T-lymphoblastoid cells. Reversal of growth inhibition by addition of cytidine.
Dahbo Y; Eriksson S
Eur J Biochem; 1985 Aug; 150(3):429-34. PubMed ID: 3874778
[TBL] [Abstract][Full Text] [Related]
15. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
Yu AL; Bakay B; Kung FH; Nyhan WL
Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
[TBL] [Abstract][Full Text] [Related]
16. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
Albert DA; Gudas LJ
J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
[TBL] [Abstract][Full Text] [Related]
17. Specificity of inhibitors of poly(ADP-ribose) synthesis. Effects on nucleotide metabolism in cultured cells.
Hunting DJ; Gowans BJ; Henderson JF
Mol Pharmacol; 1985 Aug; 28(2):200-6. PubMed ID: 2991739
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
Nandy P; Lien EJ; Avramis VI
Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
[TBL] [Abstract][Full Text] [Related]
19. In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells.
Tseng WC; Derse D; Cheng YC; Brockman RW; Bennett LL
Mol Pharmacol; 1982 Mar; 21(2):474-7. PubMed ID: 7048062
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine.
Heinemann V; Xu YZ; Chubb S; Sen A; Hertel LW; Grindey GB; Plunkett W
Mol Pharmacol; 1990 Oct; 38(4):567-72. PubMed ID: 2233693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
